CLINICAL_TRIALS
trial_result
· 2020-05-21
Clinical Trial Update: Evaluation the Effects of French Maritime Pine Bark Extract on the Clinical Status in Traumatic Brain Injury Patients [Phase 1, Phase 2]
Summary
A clinical trial evaluating French Maritime Pine Bark Extract in traumatic brain injury completed Phase 1 and Phase 2 studies.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mashhad University of Medical Sciences | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: COMPLETED